Filed in archive
Corporate and Industrial News
, Did you know
, Energy, Environment and Ecology
by ruth on March 11, 2010
The Biotechnology Industry Organization (BIO) has released a white paper on the growth and jobs potential of green chemicals and briefed Congressional staff on the commercial status of industrial biot...
Filed in archive
Corporate and Industrial News
by ruth on October 18, 2009
The Partnership for New York City and the New York City Economic Development (NYCEDC) Corporation have announced that the New York City Investment Fund (NYCIF) will provide up to $1.25 million for the...
Filed in archive
Corporate and Industrial News
by ruth on April 3, 2009
Google is launching "Google Ventures" a new venture-capital fund which will invest across a range of industries, including consumer Internet, software, clean-tech, bio-tech and health care.
...
Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
, Stem Cells
by ruth on January 28, 2009
The FDA has approved the world's first clinical trial on the use of stem cell therapy for patients with acute spinal cord injury. Geron Corporation will conduct a Phase I multi-center trial design...
Filed in archive
Corporate and Industrial News
by ruth on January 13, 2009
BIO is inviting nominations to the Biotech Humanitarian Award. The award aims to recognize a biotech professional- a scientist, researcher, academic, entrepreneur, financier, philanthropist or educato...
Filed in archive
Corporate and Industrial News
, Genomics, Proteomics and Bioinformatics
, Microbiology
by ruth on December 21, 2008
Roquette Frères has entered into an agreement to commercialize technologies by Rice University researchers, who genetically engineered E. coli bacteria to produce high yields of succinic acid through ...
Filed in archive
Corporate and Industrial News
, Other Biotechnology News
by ruth on October 11, 2008
The European Molecular Biology Organization (EMBO)will launch a new journal focusing on the interface between molecular biology and clinical
research. The EMBO Molecular Medicine journal, to be releas...
Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
by Gloria Gamat on July 24, 2008
The scientific R&D integration partner to companies in the life sciences, chemicals, energy, electronics and consumer products industries - Symyx Technologies, Inc. - has recently launched its new...
Filed in archive
Corporate and Industrial News
by Gloria Gamat on July 21, 2008
Currently, leading healthcare company Roche already owns 55.9% of all of Genetech's outstanding shares. Now Roche has offered a bid of US$43.7 billion to the rest of Genentech that it doesn't ...
Filed in archive
Corporate and Industrial News
by ruth on June 25, 2008
The publishers of BioWorld Today have released Innovations in Biotechnology 2008: Development-Stage Companies and Scientific Findings Leading the Way - an executive report focusing on the innovative c...
Filed in archive
Corporate and Industrial News
by ruth on June 18, 2008
The Biomarkers Consortium, a collaborative public-private partnership managed by the Foundation for the National Institutes of Health (FNIH), will announce at 2008 BIO its future strategic focus on Hi...
Filed in archive
Corporate and Industrial News
, Genomics, Proteomics and Bioinformatics
by ruth on June 11, 2008
Three DNA sequencing companies have joined an international research consortium called 1000 Genomes, aimed at creating a new map of the human genome that will provide a view of biomedically relevant D...
Filed in archive
Corporate and Industrial News
by ruth on June 5, 2008
Ernst & Young has named Jean-Paul Clozel, founder of Switzerland-based biotech firm Actelion Pharmaceuticals Ltd., as the World Entrepreneur Of The Year 2008. Founded in 1997, Actelion develops sm...
Filed in archive
Corporate and Industrial News
, Meetings and Other Events
by ruth on April 20, 2008
What: Pharma CI Conference and Exhibition
When: September 15-17, 2008
Where: sheraton at Woodbridge Place Hotel in Iselin, New Jersey
* The Pharma CI Conference is widely attended by a large variety ...
Filed in archive
Corporate and Industrial News
, Food and Agriculture
, Genomics, Proteomics and Bioinformatics
by ruth on February 19, 2008
A paper published in the January-February 2008 issue of Agronomy Journal explores the profitability of transgenic cotton cultivars with pest-managing traits.
Field experiments were conducted to compar...
Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
by ruth on February 11, 2008
Richmond-based Insmed, Inc has just launched a broad follow-on biologics education campaign. Part of the innovative campaign is the launch of a YouTube video on Friday to encourage an on-line conversa...
Filed in archive
Corporate and Industrial News
by ruth on January 28, 2008
Roche has announced that it will invest around $430 million Swiss francs ($387 million) in biotech drug research in its production sites Switzerland and Germany.
Around 280 million Swiss francs will b...
Filed in archive
Corporate and Industrial News
by ruth on January 4, 2008
BioWorld Today has released the 2008 Asia Pacific Biotechnology VC Directory which lists more than 100 VC firms that funds biomedical research in China, India, Korea, Australia, New Zealand and nine o...
Filed in archive
Corporate and Industrial News
, Food and Agriculture
, Patents and Intellectual Property Rights
by ruth on December 12, 2007
The Global Institute for Bio-Exploration, GIBEX, a joint initiative of the University of Illinois and Rutgers University, The Global Institute for Bio-Exploration, a joint initiative of the Universit...
Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
by ruth on November 30, 2007
Sanofi-Aventis is purchasing additional 12 million shares on biotech firm Regeneron for $400 million, upping its shares from 4% to 19%.
As part of the new deal, Sanofi and Regeneron plan to bring tw...
Filed in archive
Corporate and Industrial News
by ruth on November 30, 2007
According to the national venture capital association, venture capital investing in the biotechnology arena continue to be robust.
Biotechnology had $1.1 billion going into 99 deals in the third qua...
Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
by ruth on October 30, 2007
Foolowing the results of the a study on the efficacy and safety of Trasylol, a drug used to prevent excessive bleeding during heart bypass surgery, the FDA issued a warning that the drug also raises t...
Filed in archive
Corporate and Industrial News
, Stem Cells
by ruth on October 4, 2007
Three of the biggest European pharmaceutical companies -GlaxoSmithKline, AstraZeneca and Roche- have launched the Stem Cells for Safer Medicines, or SC4SM, a collaboration to develop stem cells for sa...
Filed in archive
Corporate and Industrial News
, Meetings and Other Events
by ruth on September 7, 2007
What: BIO Investor Forum 2007
When: October 9-11, 2007
Where: Palace Hotel, San Francisco
The BIO Investor Forum 2007 showcases leading public and private biotechnology companies, from small to mid...
Filed in archive
Corporate and Industrial News
, Diagnostics, Methodologies and Instrumentation
, Genomics, Proteomics and Bioinformatics
, Patents and Intellectual Property Rights
by ruth on August 13, 2007
Oregon Health & Science University researchers have genetically engineered mice to produce human liver cells which could be used in studies for testing the safety and efficacy of drug lead candida...
Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
by ruth on July 26, 2007
Almost $9M in grants has been received by Biodesign Institute for the development of a preventive vaccine against cancer.
Stephen Albert Johnston, PhD, director of the institute's Center for Inno...
Filed in archive
Corporate and Industrial News
by ruth on July 5, 2007
After a long-awaited deal, Nestle has confirmed its successful take-over of Novartis Medical Nutrition to the tune of US$2.5bn.
Not only will the deal strengthen nestle's health and nutrition div...
Filed in archive
Corporate and Industrial News
, Diagnostics, Methodologies and Instrumentation
by ruth on June 13, 2007
The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH) will grant a total of $20.65 million to research institutions around the country in 14 High-End Ins...
Filed in archive
Corporate and Industrial News
, Energy, Environment and Ecology
by ruth on June 7, 2007
The International Center for Advanced Renewable Energy and Sustainability (I-CARES) has been spearheaded by the Washington University in St. Louis to encourage and coordinate university-wide and exter...
Filed in archive
Corporate and Industrial News
by ruth on June 6, 2007
Biotech giant Amgen, Inc has agreed to buy Ilypsa, a privately-held, Sand Francisco based firm focusing on the development of drugs against kidney disease, for $420 million. Ilypsa's lead drug can...
